Data repository for ALS and other motor neuron disorders
Official title: ALS/MND Natural History Study Data Repository
Run by Massachusetts General Hospital · NCT05966038 · Data updated 2026-11-12
This study collects and shares information from people with ALS and other motor neuron disorders to help researchers learn more about these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 18 sites (Loma Linda, California and 17 other locations) |
| Status | Recruiting |
| Started | April 1, 2015 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | May 20, 2026 |
| Trial ID | NCT05966038 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with a clinical diagnosis of ALS or other specified motor neuron disorders.
✕Probably not a fit
Patients whose conditions do not meet the criteria for any motor neuron disorder will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects and curates data from individuals diagnosed with ALS and other motor neuron disorders at multiple clinical sites. Participants provide baseline information, including demographics and disease history, and undergo regular clinical assessments to gather longitudinal data. The data is captured in the NeuroBANK platform, which allows for the linking of clinical data with biological samples and other studies. Anonymized datasets are then shared with researchers to advance understanding of these conditions.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of ALS and other motor neuron diseases, potentially leading to improved treatments and outcomes for patients.
How similar studies have gone: Other studies utilizing similar data repository approaches have shown promise in advancing research in neurodegenerative diseases.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * A clinical diagnosis of El Escorial of suspected, possible, probable, or definite ALS or * Other motor neuron disorders, including but not limited to Spinal-Bulbar Muscular Atrophy (SBMA, Kennedy's disease), Spinal Muscular Atrophy (SMA), Primary Lateral Sclerosis (PLS), Progressive Muscular Atrophy (PMA), and Progressive Bulbar Palsy (PBP) Exclusion Criteria: * Disease does not meet criteria for any motor neuron disorder
Where it's running
-
Loma Linda University Health
Loma Linda, California, United States Recruiting -
Kaiser Permanente
Los Angeles, California, United States Recruiting -
University of Florida
Gainesville, Florida, United States Recruiting -
Northwestern University
Chicago, Illinois, United States Recruiting -
Lahey Clinic
Burlington, Massachusetts, United States Recruiting -
Henry Ford Health System
Detroit, Michigan, United States Recruiting
Show 12 more locations
-
Trinity Health Michigan
Grand Rapids, Michigan, United States Recruiting -
University of Minnesota
Minneapolis, Minnesota, United States Recruiting -
Saint Louis University
St Louis, Missouri, United States Recruiting -
Providence ALS Clinic
Portland, Oregon, United States Recruiting -
Thomas Jefferson University
Philadelphia, Pennsylvania, United States Recruiting -
Temple University Lewis Katz School of Medicine
Philadelphia, Pennsylvania, United States Recruiting -
University of Pittsburgh
Pittsburgh, Pennsylvania, United States Recruiting -
Virginia Commonwealth University
Richmond, Virginia, United States Recruiting -
Hadassah Medical Organization
Jerusalem, Israel Recruiting -
Tel Aviv Medical Center
Tel Aviv, Israel Recruiting -
Centro Clinico NEMO Milano
Milan, Italy Recruiting -
Istituti Clinici Scientifici Maugeri SpA
Milan, Italy Recruiting
Study contacts
- Principal investigator: Alexander Sherman — Massachusetts General Hospital
- Study coordinator: Natalia Tarasenko
- Email: ntarasenko@mgh.harvard.edu
- Phone: 1617240346
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Imaging markers for bulbar involvement in inclusion body myositis among IBM and comparison groups
This study tests whether ultrasound and MRI can detect swallowing and bulbar muscle problems in people with inclusion body myositis.
-
Decoding Mandarin speech features from brain-surface signals
This project will try to decode imagined Mandarin speech, including lexical tones, from high-density brain-surface (ECoG) signals in adult patients who are having clinically indicated cortical electrode placement.
-
Telehealth in MND: TiM online platform for people with MND
This project lets people with MND in the UK use an online telehealth platform to learn about and sign up for MND studies and share health information from home.
-
At-home cortico-spinal tDCS for ALS.
This treatment tests whether daily at-home cortico-spinal tDCS can slow nerve damage and symptoms in adults with early ALS.
-
Cell therapy using induced pluripotent stem cells for ALS treatment
This study is testing a new cell therapy using stem cells to see if it can safely help people with ALS feel better.
-
Multicenter study using MRI to identify biomarkers in ALS patients
This study is trying to see if brain scans and blood tests can help track how ALS changes over time in patients compared to healthy people.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.